Canada · Delayed Price · Currency is CAD Healwell AI Statistics
Total Valuation
Healwell AI has a market cap or net worth of CAD 204.08 million. The enterprise value is 248.79 million.
| Market Cap | 204.08M |
| Enterprise Value | 248.79M |
Important Dates
The last earnings date was Monday, November 9, 2026.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Healwell AI has 304.60 million shares outstanding. The number of shares has increased by 54.47% in one year.
| Current Share Class | 304.60M |
| Shares Outstanding | 304.60M |
| Shares Change (YoY) | +54.47% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 12.76% |
| Owned by Institutions (%) | 8.20% |
| Float | 168.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | 1.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 35.12 |
| P/OCF Ratio | 31.08 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 42.81 |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.73.
| Current Ratio | 0.92 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | 14.85 |
| Interest Coverage | -1.52 |
Financial Efficiency
Return on equity (ROE) is -19.22% and return on invested capital (ROIC) is -10.97%.
| Return on Equity (ROE) | -19.22% |
| Return on Assets (ROA) | -4.02% |
| Return on Invested Capital (ROIC) | -10.97% |
| Return on Capital Employed (ROCE) | -9.57% |
| Weighted Average Cost of Capital (WACC) | 2.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 570 |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Healwell AI has paid 2.34 million in taxes.
| Income Tax | 2.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.46% in the last 52 weeks. The beta is -0.94, so Healwell AI's price volatility has been lower than the market average.
| Beta (5Y) | -0.94 |
| 52-Week Price Change | -48.46% |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 0.79 |
| Relative Strength Index (RSI) | 45.58 |
| Average Volume (20 Days) | 128,478 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healwell AI had revenue of CAD 130.96 million and -17.66 million in losses. Loss per share was -0.06.
| Revenue | 130.96M |
| Gross Profit | 72.11M |
| Operating Income | -19.06M |
| Pretax Income | -20.91M |
| Net Income | -17.66M |
| EBITDA | -7.93M |
| EBIT | -19.06M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 32.61 million in cash and 86.32 million in debt, with a net cash position of -53.70 million or -0.18 per share.
| Cash & Cash Equivalents | 32.61M |
| Total Debt | 86.32M |
| Net Cash | -53.70M |
| Net Cash Per Share | -0.18 |
| Equity (Book Value) | 117.79M |
| Book Value Per Share | 0.37 |
| Working Capital | -6.66M |
Cash Flow
In the last 12 months, operating cash flow was 6.57 million and capital expenditures -755,000, giving a free cash flow of 5.81 million.
| Operating Cash Flow | 6.57M |
| Capital Expenditures | -755,000 |
| Depreciation & Amortization | 11.13M |
| Net Borrowing | -4.97M |
| Free Cash Flow | 5.81M |
| FCF Per Share | 0.02 |
Margins
Gross margin is 55.06%, with operating and profit margins of -14.55% and -13.48%.
| Gross Margin | 55.06% |
| Operating Margin | -14.55% |
| Pretax Margin | -15.97% |
| Profit Margin | -13.48% |
| EBITDA Margin | -6.05% |
| EBIT Margin | -14.55% |
| FCF Margin | 4.44% |
Dividends & Yields
Healwell AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -54.47% |
| Shareholder Yield | -54.47% |
| Earnings Yield | -8.41% |
| FCF Yield | 2.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Healwell AI is 1.82, which is 171.34% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 1.82 |
| Price Target Difference | 171.34% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 20.27% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |